Zsolt Orosz

Summary

Country: Hungary

Publications

  1. ncbi Epithelial mesothelioma with deciduoid features
    Z Orosz
    Center of Diagnostic and Experimental Tumour Pathology, National Institute of Oncology, Budapest, Hungary
    Virchows Arch 434:263-6. 1999
  2. ncbi [Reclassification of gastrointestinal mesenchymal tumors]
    Zsolt Orosz
    Országos Onkológiai Intézet, Budapest 1122, Hungary
    Magy Onkol 50:287-92. 2006
  3. ncbi Recurrent giant fibroepithelial stromal polyp of the vulva associated with congenital lymphedema
    Zsolt Orosz
    Department of Oncopathology, National Institute of Oncology, Budapest, Hungary
    Gynecol Oncol 98:168-71. 2005
  4. ncbi [Histopathologic diagnosis of gastrointestinal stromal tumor (GIST)]
    Zsolt Orosz
    Országos Onkológiai Intézet, Daganatpathologiai Osztaly, Budapest
    Orv Hetil 146:923-8. 2005
  5. ncbi Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases
    Zsolt Orosz
    Department of Human and Experimental Tumor Pathology, National Institute of Oncology, Budapest H 1122, Hungary
    Pathol Oncol Res 11:11-21. 2005
  6. ncbi [Pitfalls in the diagnosis of malignant melanoma]
    Zsolt Orosz
    Országos Onkológiai Intézet, Humán és Kísérletes Daganatpathológiai Osztály, Budapest, Hungary
    Magy Onkol 47:27-39. 2003
  7. ncbi Pleomorphic liposarcoma of a young woman following radiotherapy for epithelioid sarcoma
    Z Orosz
    Department of Human and Experimental Tumor Pathology, National Institute of Oncology, Ráth György u 7 9, Budapest, H 1122, Hungary
    Pathol Oncol Res 6:287-91. 2000
  8. ncbi Syndecan-1 expression in different soft tissue tumours
    Z Orosz
    Department of Human and Experimental Tumour Pathology, National Institute of Oncology, H 1122 Budapest, Ráth György u 7 9, Hungary
    Anticancer Res 21:733-7. 2001
  9. ncbi Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial
    Csaba Polgar
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    Int J Radiat Oncol Biol Phys 69:694-702. 2007
  10. ncbi [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature]
    Zoltan Matrai
    Országos Onkológiai Intézet, Budapest
    Orv Hetil 147:2011-20. 2006

Collaborators

Detail Information

Publications38

  1. ncbi Epithelial mesothelioma with deciduoid features
    Z Orosz
    Center of Diagnostic and Experimental Tumour Pathology, National Institute of Oncology, Budapest, Hungary
    Virchows Arch 434:263-6. 1999
    ..The patient died 11 months after diagnosis. Post-mortem examination revealed extensive extraperitoneal spread...
  2. ncbi [Reclassification of gastrointestinal mesenchymal tumors]
    Zsolt Orosz
    Országos Onkológiai Intézet, Budapest 1122, Hungary
    Magy Onkol 50:287-92. 2006
    ..Based on our experience, in case of abdominal tumors of uncertain localization, immunohistochemical markers of CD117, CD34, S100 and desmin provide a proper tool for precise identification of the tumor entity including GIST...
  3. ncbi Recurrent giant fibroepithelial stromal polyp of the vulva associated with congenital lymphedema
    Zsolt Orosz
    Department of Oncopathology, National Institute of Oncology, Budapest, Hungary
    Gynecol Oncol 98:168-71. 2005
    ..Fibroepithelial stromal polyp is generally an easily recognizable entity, but certain cases cause differential diagnostic problems...
  4. ncbi [Histopathologic diagnosis of gastrointestinal stromal tumor (GIST)]
    Zsolt Orosz
    Országos Onkológiai Intézet, Daganatpathologiai Osztaly, Budapest
    Orv Hetil 146:923-8. 2005
    ..The aim of this synopsis is to overview development of our knowledge about GIST and to discuss differential diagnostic problems. Basic molecular mechanisms responsible for development of GIST are also reviewed...
  5. ncbi Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases
    Zsolt Orosz
    Department of Human and Experimental Tumor Pathology, National Institute of Oncology, Budapest H 1122, Hungary
    Pathol Oncol Res 11:11-21. 2005
    ..6% of examined cases. Only one case showed desmin reactivity and seven had S100 positive tumor cells. For h-caldesmon 39 cases proved to be positive (60.9% of the tested cases)...
  6. ncbi [Pitfalls in the diagnosis of malignant melanoma]
    Zsolt Orosz
    Országos Onkológiai Intézet, Humán és Kísérletes Daganatpathológiai Osztály, Budapest, Hungary
    Magy Onkol 47:27-39. 2003
    ..Lymph node metastasis of melanoma, when the primary tumour is not known, may raise the possibility of interdigitating reticulum cell tumour or anaplastic large cell lymphoma...
  7. ncbi Pleomorphic liposarcoma of a young woman following radiotherapy for epithelioid sarcoma
    Z Orosz
    Department of Human and Experimental Tumor Pathology, National Institute of Oncology, Ráth György u 7 9, Budapest, H 1122, Hungary
    Pathol Oncol Res 6:287-91. 2000
    ..This tumor showed dedifferentiation toward pleomorphic malignant fibrous histiocytoma. Our case represents a unique case of postirradiation liposarcoma developed on the base of ES...
  8. ncbi Syndecan-1 expression in different soft tissue tumours
    Z Orosz
    Department of Human and Experimental Tumour Pathology, National Institute of Oncology, H 1122 Budapest, Ráth György u 7 9, Hungary
    Anticancer Res 21:733-7. 2001
    ..In vitro studies have suggested that expression of syndecan-1 (CD138) is correlated with morphologic phenotype (epithelioid or spindle) of cultured tumour cells...
  9. ncbi Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial
    Csaba Polgar
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    Int J Radiat Oncol Biol Phys 69:694-702. 2007
    ..To report the 5-year results of a randomized study comparing the survival and cosmetic results of breast-conserving treatment with partial breast irradiation (PBI) or conventional whole breast irradiation (WBI)...
  10. ncbi [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature]
    Zoltan Matrai
    Országos Onkológiai Intézet, Budapest
    Orv Hetil 147:2011-20. 2006
    ..AIM AUTHORS: We studied the degree of histopathological regression after radiotherapy regimens commonly used in their clinical practice, and its effect on the pathology of by clinically founded T3-T4 rectal cancer...
  11. ncbi Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil
    Erika Hitre
    National Institute of Oncology, Budapest, Hungary
    Pharmacogenet Genomics 15:723-30. 2005
    ....
  12. doi [Long-term experience with multidisciplinary therapy of twenty-six patients with dermatofibrosarcoma protuberans]
    Zoltan Matrai
    Országos Onkológiai Intézet, Altalános és Mellkassebészeti Osztály, Budapest
    Orv Hetil 150:1894-902. 2009
    ..Initial treatment is the radical surgical excision, using traditional wide excision or Mohs surgery. In case of positive surgical margin or local recurrence, radio-chemotherapy and recently imatinib mesylate is used as adjuvant therapy...
  13. ncbi [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]
    Gábor Péley
    Országos Onkológiai Intézet, Budapest 1122, Hungary
    Magy Onkol 50:19-23. 2006
    ..Patients with clinically lymph node-negative breast cancer less than 3 cm in size after neoadjuvant chemotherapy were enrolled in the study...
  14. ncbi Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy--4-year results of a randomized trial
    Katalin Lövey
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    Int J Radiat Oncol Biol Phys 69:724-31. 2007
    ....
  15. ncbi High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study
    Csaba Polgar
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    Int J Radiat Oncol Biol Phys 60:1173-81. 2004
    ....
  16. ncbi Clinical significance of sentinel lymph node involvement in malignant melanoma
    Gabriella Liszkay
    National Institute of Oncology, Budapest, H 1122, Hungary
    Pathol Oncol Res 9:184-7. 2003
    ..7% and 79.9%, respectively for correct classification rates. Based on our study and data from the literature, we suggest SLN-positivity as equally strong poor prognosis factor for skin melanoma as the tumor thickness...
  17. ncbi Relationship between sentinel lymph node status and regression of primary malignant melanoma
    Gabriella Liszkay
    Department of Dermatology, National Institute of Oncology, Budapest, Hungary
    Melanoma Res 15:509-13. 2005
    ..We failed to demonstrate a significant relationship between the presence of circulating tumour cells and either primary tumour regression or the sentinel lymph node status...
  18. ncbi [Metastatic breast cancer in the uterine cervix: two cases of a rare occurrence]
    Ottó Lehoczky
    Országos Onkológiai Intézet, Nógyógyászati Onkológiai Osztálya, Budapest
    Orv Hetil 144:1637-8. 2003
    ..The final diagnoses was proved by cervical conisation in the first patient and by hysterectomy in the second one. Authors call attention for the possibility of the rare site of symptom free recurrence...
  19. doi The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast
    Csaba Polgar
    Department of Radiotherapy, National Institute of Oncology, Rath Gy u 7 9, Budapest, 1122, Hungary
    Pathol Oncol Res 14:179-92. 2008
    ....
  20. doi Subcutaneous calcification as a delayed complication of radiotherapy: a case report and review of the literature
    Zoltán Zaka
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    Pathol Oncol Res 14:485-8. 2008
    ..In our case the calcification developed in abnormal skin after telecobalt radiotherapy for mediastinal Hodgkin's disease. Ichthyosis is a systemic cutaneous disease and may increase the risk of late radiation complications...
  21. ncbi [Histopathological prognostic factors of malignant melanoma]
    Vanda Plótár
    Országos Onkológiai Intézet, Daganatpathologiai Osztaly, 1122 Budapest
    Magy Onkol 51:39-46. 2007
    ..It is important to standardize the content of the histopathological reports in a reproducible way...
  22. doi [Long-term experience with therapy of a female patient with Gardner's syndrome, first presenting with extra-abdominal desmoid tumor, and review of the literature]
    Zoltan Matrai
    Országos Onkológiai Intézet, Altalános és Mellkassebészeti Osztály, Budapest, Hungary
    Magy Seb 62:75-82. 2009
    ..Such patients should be evaluated with genetic testing followed by colonoscopy. Desmoid tumours should be managed in a multidisciplinary setting, as well...
  23. ncbi Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature
    Janos Fodor
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    J Am Acad Dermatol 54:499-504. 2006
    ..As shown by a review of the literature, angiosarcomas are often resistant to surgery, chemotherapy, and radiotherapy, and targeted therapy against tumor biological properties may be a new approach to angiosarcoma treatment...
  24. ncbi [Laboratory markers of melanoma progression]
    Teodóra Bánfalvi
    Országos Onkológiai Intézet, Budapest, Hungary
    Magy Onkol 47:89-104. 2003
    ..Determination of serum concentration of MIA and tyrosinase are also reliable markers in malignant melanoma. The other investigated markers are not well known yet or do not provide useful information to the clinicians...
  25. ncbi [Atypical glandular cells (AGC) on Papanicolaou smears--the great challenge of cervix screening programs]
    Ferenc Schneider
    Országos Onkológiai Intézet, Cytopathologiai Osztály, Budapest
    Orv Hetil 146:2239-46. 2005
    ..The "grey zone" diagnostic category for glandular cells in the Bethesda System 2001 (TBS 2001) has undergone significant modification since its last version in 1991...
  26. ncbi Her-2 oncogene amplification, chromosome 17 and DNA ploidy status in synovial sarcoma
    Zoltan Sapi
    Department of Pathology, St John s Hospital, Budapest, H 1125, Hungary
    Pathol Oncol Res 11:133-8. 2005
    ..Furthermore, this may open a theoretically new treatment possibility with Trastuzumab for Her-2-amplified cases of SS...
  27. ncbi [Effect of imatinib treatment of gastrointestinal stromal tumors]
    Sandor Eckhardt
    Országos Onkológiai Intézet, B Belgyógyászati Osztály, Budapest
    Orv Hetil 144:2207-12. 2003
    ..These tumours are characterized by the presence of C-KIT (a transmembrane tyrosin kinase) mutation which can be specified by CD117 expression. Imatinib (2-fenilaminopirimidine) is a selective inhibitor of the mutated C-KIT...
  28. ncbi Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma
    O Esik
    Department of Radiotherapy, Semmelweis University, National Institute of Oncology, Budapest, Hungary
    Cancer 91:2084-95. 2001
    ..A high rate of undetectable metastases is hypothesized to be responsible for the frequent mismatch between the apparent relatively small tumor burden and the elevated plasma tumor marker level...
  29. ncbi [Positron emission tomography ia an effective tool in modern oncology]
    O Esik
    Országos Onkológiai Intézet, Budapest
    Orv Hetil 140:2555-62. 1999
    ..Application of PET may be indicated in all cases when the ultimate question is a non-invasive estimation of viable tumorous tissue...
  30. ncbi Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients
    Vilmos Adleff
    Department of Clinical Research, National Institute of Oncology, H 1122 Budapest, Rath Gy u 7 9, Hungary
    Int J Cancer 108:852-6. 2004
    ..The lack of similar genotype effect seen with TS1494del polymorphism and the increased presence of one genotype combination (3R3R&ins6/del6) in the patient group suggest a possible TS haplotype effect influencing CRC risk...
  31. ncbi [Endometrial cancer in a young woman taking oral contraceptives for a long time]
    Géza Krascsenits
    Nogyógyászati Osztály, Országos Onkológiai Intézet, Budapest
    Orv Hetil 143:2645-6. 2002
    ..In such cases histological examination is strongly recommended, since irregular vaginal bleeding might be caused by malignant disease even at young women using sequential oral contraceptives...
  32. ncbi Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis
    Jozsef Timar
    Department of Tumor Progression, National Institute of Oncology, Budapest, H 1122, Hungary
    Pathol Oncol Res 8:204-19. 2002
    ..Without the integration of these methods into the prognostic/predictive pathological protocols it is difficult to envision significant improvement in the results of cancer therapy...
  33. doi Myofibroblastic sarcoma of the base of tongue. Case report and review of the literature
    Zoltán Takácsi-Nagy
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    Strahlenther Onkol 185:198-201. 2009
    ..Low-grade myofibroblastic sarcoma shows a wide anatomic distribution with a predilection for the head-and-neck region; however, intermediate- and high-grade myofibroblastic sarcomas in this localization are exceptional...
  34. ncbi Giant cystic pheochromocytoma located in the renal hilus
    Zsombor Melegh
    Department of Molecular Pathology, National Institute of Oncology, Budapest, Hungary
    Pathol Res Pract 198:103-6; discussion 107-8. 2002
    ..During surgery the left kidney, with a cystic tumor located in the hilus, was removed. The postoperative pathologic diagnosis was pheochromocytoma located in the hilus of the left kidney...
  35. ncbi Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial
    Csaba Polgar
    Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
    Strahlenther Onkol 178:615-23. 2002
    ..To evaluate the effect of electron and high-dose-rate brachytherapy (HDR BT) boost on local tumor control (LTC), side effects and cosmesis after breast-conserving surgery (BCS) in a prospective randomized study...
  36. ncbi [Prognostic significance of sex steroid and hypophyseal hormones in head and neck squamous cell carcinoma]
    Eva Remenar
    Fej Nyak, Allcsont, Laser és Helyreállító Plasztikai Sebészeti Osztály, Országos Onkológiai Intézet, Budapest 1122, Hungary
    Magy Onkol 47:155-9. 2003
    ..to investigate the clinical outcome of HNSCC patients, and their hormonal status...
  37. ncbi Healing of esophageal anastomoses performed with the biofragmentable anastomosis ring versus the end-to-end anastomosis stapler: comparative experimental study in dogs
    Tibor Kovacs
    Department of General and Thoracic Surgery, National Institute of Oncology, Rath Gy u 7 9, 1122 Budapest, Hungary
    World J Surg 27:465-72. 2003
    ..The BAR method is simple, quick, and safe; and it seems to be a feasible procedure for creating intrathoracic esophageal anastomoses in dogs...
  38. ncbi Complex pathological diagnosis of granulocytic sarcoma: apropos of a case
    Erika Toth
    Department of Molecular Pathology, National Institute of Oncology, Budapest, Hungary
    Pathol Res Pract 198:55-7. 2002
    ....